Clinical trial
China Salt Substitute Study in Tibet: Efficacy of Salt Substitute in Reducing Blood Pressure in Hypertensive Adults
NCT01429246 is registered in ClinicalTrials.gov with The George Institute for Global Health, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- China Salt Substitute Study in Tibet: Efficacy of Salt Substitute in Reducing Blood Pressure in Hypertensive Adults
- Lead sponsor
- The George Institute for Global Health, China
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 28, 2009
- Completion date
- August 31, 2009
- Enrollment
- 282 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.